Royal Bank of Canada

Selected news for the capital firm - Royal Bank of Canada, collected since 10/2017. This capital firm shares healthcare news with Wolfe Research, UnitedHealth Group, COVID-19, Bausch Health, Karuna and over a hundred others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
1/12/2022 CVS Health (NYSE:CVS) Reaches New 52-Week High Following Analyst Upgrade - Stock Observer thestockobserver.com ... the company. Raymond James boosted their target price on shares of CVS Health from $95.00 to $115.00 and gave the company a “strong-buy” rating in a research report on Thursday, November 4th. Royal Bank of Canada boosted their target price on shares of CVS Health from $107.00 to $119.00 and gave the company an “outperform” rating in a research report on Friday, December 10th. Finally, JPMorgan Chase ...
1/12/2022 Karyopharm Therapeutics (NASDAQ:KPTI) Stock Price Up 2.5% on Analyst Upgrade zolmax.com ... Several other brokerages have also recently weighed in on KPTI. Zacks Investment Research upgraded Karyopharm Therapeutics from a “sell” rating to a “hold” rating in a research report on Tuesday, November 9th. Royal Bank of Canada lifted their price target on Karyopharm Therapeutics from $8.00 to $9.00 and gave the company a “sector perform” rating in a research report on Thursday, December 9th. Finally, Morgan Stanley cut ...
1/12/2022 Brokers Set Expectations for REGENXBIO Inc.'s FY2026 Earnings (NASDAQ:RGNX) - Slater Sentinel slatersentinel.com ... compared to the consensus estimate of $49.35 million. During the same quarter in the previous year, the firm earned $0.23 EPS.Several other equities research analysts have also recently weighed in on the company. Royal Bank of Canada upped their price target on REGENXBIO from $50.00 to $55.00 and gave the stock a “sector perform” rating in a research note on Tuesday, September 14th. SVB Leerink reduced their price ...
1/12/2022 Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) to Post FY2026 Earnings of $3.15 Per Share, Jefferies Financial Group Forecasts - Transcript Daily transcriptdaily.com ... also weighed in on AUPH. SVB Leerink lifted their price objective on Aurinia Pharmaceuticals from $28.00 to $35.00 and gave the stock an “outperform” rating in a research report on Thursday, November 4th. Royal Bank of Canada lifted their price objective on Aurinia Pharmaceuticals from $23.00 to $34.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 26th. Oppenheimer upgraded Aurinia Pharmaceuticals from ...
1/12/2022 Kilroy Realty (NYSE:KRC) Upgraded at Zacks Investment Research dispatchtribunal.com ... a report on Tuesday, October 12th. KeyCorp lowered their target price on Kilroy Realty from $91.00 to $85.00 and set an overweight rating on the stock in a research report on Thursday, October 14th. Royal Bank of Canada raised Kilroy Realty from a sector perform rating to an outperform rating and upped their target price for the stock from $75.00 to $80.00 in a research report on Friday, November 19th ...
1/12/2022 Kilroy Realty (NYSE:KRC) Upgraded to Buy at Zacks Investment Research thelincolnianonline.com ... the stock. Deutsche Bank Aktiengesellschaft raised shares of Kilroy Realty from a sell rating to a hold rating and set a $73.00 price objective for the company in a report on Tuesday, October 12th. Royal Bank of Canada raised shares of Kilroy Realty from a sector perform rating to an outperform rating and upped their price objective for the stock from $75.00 to $80.00 in a report on Friday, November ...
1/12/2022 Avalo Therapeutics (NASDAQ:AVTX) Downgraded to “Sell” at Zacks Investment Research thelincolnianonline.com ... unmet clinical need in immunology, immuno-oncology and rare genetic diseases. Avalo Therapeutics Inc., formerly known as Cerecor, is based in WAYNE, Pa. “A number of other analysts also recently commented on AVTX. Royal Bank of Canada initiated coverage on Avalo Therapeutics in a research report on Friday, September 24th. They set an outperform rating and a $6.00 target price on the stock. Oppenheimer restated a buy rating and ...
1/11/2022 Raymond James Financial Services Advisors Inc. Decreases Holdings in Centene Co. (NYSE:CNC) - Transcript Daily transcriptdaily.com ... Centene by 4.3% during the second quarter. Price T Rowe Associates Inc. MD now owns 29,512,722 shares of the company’s stock worth $2,152,363,000 after acquiring an additional 1,205,189 shares during the period. Finally, Royal Bank of Canada raised its stake in Centene by 126.4% during the second quarter. Royal Bank of Canada now owns 2,098,117 shares of the company’s stock worth $153,016,000 after acquiring an additional 1,171,509 shares ...
1/11/2022 UnitedHealth Group (NYSE:UNH) Now Covered by Analysts at Edward Jones - Mayfield Recorder Mayfield Recorder ... also recently issued reports about the company. SVB Leerink began coverage on UnitedHealth Group in a report on Monday, September 27th. They set an outperform rating and a $480.00 price target for the company. Royal Bank of Canada increased their price target on UnitedHealth Group from $476.00 to $512.00 and gave the stock an outperform rating in a report on Wednesday, December 1st. The Goldman Sachs Group began coverage on ...
1/11/2022 Morgan Stanley Lowers Teleflex (NYSE:TFX) to Equal Weight dispatchtribunal.com ... the stock from $465.00 to $325.00 in a research note on Tuesday, January 4th. TheStreet downgraded Teleflex from a b rating to a c+ rating in a research report on Wednesday, December 1st. Finally, Royal Bank of Canada began coverage on Teleflex in a research report on Thursday, December 9th. They set an outperform rating and a $415.00 target price for the company. One analyst has rated the stock with ...
1/11/2022 Principal Financial Group Inc. Has $73.82 Million Stock Position in Principal Healthcare Innovators Index ETF (NASDAQ:BTEC) dispatchtribunal.com ... Principal Healthcare Innovators Index ETF by 30.7% in the 2nd quarter. Morgan Stanley now owns 151,509 shares of the company’s stock valued at $9,224,000 after purchasing an additional 35,572 shares during the period. Royal Bank of Canada grew its stake in shares of Principal Healthcare Innovators Index ETF by 0.9% in the 2nd quarter. Royal Bank of Canada now owns 70,073 shares of the company’s stock valued at ...
1/11/2022 Edwards Lifesciences (NYSE:EW) Given New $144.00 Price Target at Credit Suisse Group etfdailynews.com ... note issued to investors on Friday, Analyst Ratings Network reports. Credit Suisse Group currently has an outperform rating on the medical research company’s stock.Several other analysts have also issued reports on EW. Royal Bank of Canada initiated coverage on shares of Edwards Lifesciences in a research report on Thursday, December 9th. They issued an outperform rating and a $142.00 price target on the stock. Piper Sandler raised their ...
1/11/2022 Q4 2022 Earnings Forecast for Exelixis, Inc. Issued By Piper Sandler (NASDAQ:EXEL) zolmax.com ... on Wednesday, November 3rd. Oppenheimer decreased their target price on shares of Exelixis from $30.00 to $29.00 and set an “outperform” rating on the stock in a research report on Tuesday, November 2nd. Royal Bank of Canada decreased their target price on shares of Exelixis from $32.00 to $31.00 and set an “outperform” rating on the stock in a research report on Wednesday, November 3rd. Jefferies Financial Group ...
1/11/2022 eHealth (NASDAQ:EHTH) Stock Rating Lowered by Credit Suisse Group - Transcript Daily transcriptdaily.com ... Tuesday, November 9th. Craig Hallum cut eHealth from a buy rating to a hold rating and dropped their price objective for the company from $75.00 to $33.00 in a report on Tuesday, November 9th. Royal Bank of Canada dropped their price objective on eHealth from $62.00 to $28.00 and set a sector perform rating for the company in a report on Tuesday, November 9th. TheStreet cut eHealth from a c ...
1/11/2022 Medtronic (NYSE:MDT) Downgraded by BTIG Research to “Neutral” thelincolnianonline.com ... lowered shares of Medtronic from an overweight rating to an equal weight rating and dropped their price target for the stock from $137.00 to $110.00 in a research report on Thursday, December 16th. Finally, Royal Bank of Canada began coverage on shares of Medtronic in a research report on Thursday, December 9th. They issued an outperform rating and a $140.00 price target for the company. Nine equities research analysts have ...
1/11/2022 Medtronic (NYSE:MDT) Rating Lowered to Neutral at BTIG Research dispatchtribunal.com ... in a research note published on Monday morning, Analyst Price Targets reports. They currently have $104.00 target price on the medical technology company’s stock.MDT has been the subject of several other reports. Royal Bank of Canada began coverage on shares of Medtronic in a research report on Thursday, December 9th. They issued an outperform rating and a $140.00 target price for the company. Citigroup lowered their price objective ...
1/11/2022 Humana (NYSE:HUM) Price Target Cut to $410.00 by Analysts at Morgan Stanley - Ticker Report Ticker Report ... 472.00 price target on the stock. Truist Securities boosted their price objective on Humana from $500.00 to $520.00 and gave the stock a hold rating in a research report on Wednesday, January 5th. Finally, Royal Bank of Canada boosted their price objective on Humana from $479.00 to $525.00 and gave the stock an outperform rating in a research report on Thursday, November 4th. Eight analysts have rated the stock with ...
1/11/2022 Humana (NYSE:HUM) Price Target Cut to $410.00 by Analysts at Morgan Stanley - Watch List News watchlistnews.com ... a report published on Friday, Analyst Ratings Network reports. Morgan Stanley currently has an equal weight rating on the insurance provider’s stock.HUM has been the topic of a number of other reports. Royal Bank of Canada raised their price objective on Humana from $479.00 to $525.00 and gave the stock an outperform rating in a report on Thursday, November 4th. SVB Leerink raised their price objective on Humana ...
1/11/2022 Vocera Communications (NYSE:VCRA) Rating Lowered to Neutral at BTIG Research dispatchtribunal.com ... 29th. Zacks Investment Research raised Vocera Communications from a hold rating to a strong-buy rating and set a $75.00 price target on the stock in a research report on Wednesday, December 29th. Finally, Royal Bank of Canada upped their target price on Vocera Communications from $43.00 to $51.00 and gave the company a sector perform rating in a research report on Friday, October 29th. Nine equities research analysts have ...
1/11/2022 HealthStream, Inc. (NASDAQ:HSTM) Shares Purchased by New York State Common Retirement Fund Daily Political ... York State Common Retirement Fund owned 0.24% of HealthStream worth $2,146,000 at the end of the most recent quarter.Other hedge funds and other institutional investors have also modified their holdings of the company. Royal Bank of Canada grew its stake in HealthStream by 550.3% during the 2nd quarter. Royal Bank of Canada now owns 2,016 shares of the technology company’s stock valued at $56,000 after purchasing an additional ...